Amid a push to phase out animal testing, Charles River’s Steve Bulera notes that the implementation of alternative methods ...

Although Saxenda is the first generic GLP-1 to hit the US market, its sales will likely be overshadowed by next-gen drugs such as Wegovy.

Part of $1 billion investment strategy, PCI Pharma Services completes acquisition of Ajinomoto Althea, enhancing US drug ...

Novo Nordisk has turned to Replicate Bioscience’s RNA drug platform in a lucrative research collaboration, marking its latest ...

The vaccine, also named the varicella jab owing to the medical term for chickenpox, will be added to the existing MMR (measles, mumps, rubella) vaccine. This will create a new MMRV vaccine, a combined ...

ExCellThera has announced that the European Commission (EC) has granted conditional marketing authorisation for its Zemcelpro ...

Moderna has secured approval from Health Canada for Spikevax, its updated Covid-19 mRNA vaccine, which targets the SARS-CoV-2 ...

Analysts and charities have identified Gilead’s new HIV prevention injection as key to curbing infection rates ...

While 84% of products remain in early development, the four late-stage contenders are poised for regulatory approval in East ...

Eli Lilly experienced the highest revenue growth of 32% to $45bn, followed by Novo Nordisk with 25.5% growth to $42.1bn.

Daiichi Sankyo and AstraZeneca have received approval from China’s National Medical Products Administration (NMPA) for ...

Health Canada has granted a Notice of Compliance (NOC) to AbbVie’s Rinvoq (upadacitinib) to treat adult patients diagnosed with chronic autoimmune vasculitis, giant cell arteritis (GCA).